Key facts
- This page summarizes Karen L. Smith's Form 4 filing for Aurinia Pharmaceuticals Inc. (AUPH).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 25 Nov 2024, 16:38.
Karen L. Smith - 21 Nov 2024 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)
- Reporting relationship
- Director
- Issuer ticker
- AUPH
- Reported as of
- 21 Nov 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 25 Nov 2024, 16:38:58 UTC
- Prior SEC filing
- 12 Nov 2024
- Next SEC filing
- 26 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Karen L. Smith
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Karen L. Smith filed Form 4 for Aurinia Pharmaceuticals Inc. (AUPH) on 25 Nov 2024.
Change
- Previous filing in this sequence was filed on 12 Nov 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AUPH
transaction
Common Shares
Award
- Transaction value
- $0
- Shares
- +12,135
- Change %
- +96%
- Price
- $0.000000
- Shares after
- 24,807
- Date
- 21 Nov 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AUPH
transaction
Derivative
Director Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +18,641
- Change %
- Price
- $0.000000
- Shares after
- 18,641
- Date
- 21 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 18,641
- Exercise price
- $8.24
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents grant of Restricted Stock Units (RSUs) payable solely in common shares of the Issuer. The shares subject to the RSUs shall vest one year from date of grant.
Footnote F2
The options shall vest one year from date of grant.